Chris has over 17 years’ experience in consulting for the pharmaceutical industry with experience spanning P&R and commercial strategy. He leads a broad range of market access and pricing projects at Huron in both product-related MA strategy work as well as MA planning, process and organizational capability building projects. He has particular expertise in value proposition development, including the implications for payer evidence development and integration with cross functional brand plans, as well as expertise in innovative contracting solutions. Chris has had exposure to many therapeutic areas over his career, including issues around pricing and access for rare diseases, as well as in-depth knowledge of oncology and cardiovascular/metabolic disease areas.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)